Published in Br J Gen Pract on April 01, 1998
Systematic review of studies of quality of clinical care in general practice in the UK, Australia and New Zealand. Qual Health Care (2001) 8.83
Blood pressure control in treated hypertensive patients: clinical performance of general practitioners. Br J Gen Pract (2001) 2.68
Addressing barriers to change: an RCT of practice-based education to improve the management of hypertension in the elderly. Br J Gen Pract (1999) 1.10
Improving management of hypertension in general practice: a randomised controlled trial of feedback derived from electronic patient data. Br J Gen Pract (2005) 1.04
Zero end-digit preference in recorded blood pressure and its impact on classification of patients for pharmacologic management in primary care - PREDICT-CVD-6. Br J Gen Pract (2007) 0.94
Antihypertensive drug prescribing in Grampian. Br J Clin Pharmacol (2005) 0.89
Performance indicators for primary care groups. Current indicators have been chosen for ease of collection rather than scientific validity. BMJ (1999) 0.87
What benefit do patients expect from adding second and third antihypertensive drugs? Br J Clin Pharmacol (2002) 0.78
Recording blood pressure readings in elderly patients' charts: what patient and physician characteristics make it more likely? Can Fam Physician (2008) 0.75
Randomization by cluster. Sample size requirements and analysis. Am J Epidemiol (1981) 9.21
Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ (1993) 8.24
Hypertension--a community problem. Am J Med (1972) 7.12
Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA (1994) 4.44
What constitutes controlled hypertension? Patient based comparison of hypertension guidelines. BMJ (1996) 4.11
Control of blood pressure in Scotland: the rule of halves. BMJ (1990) 3.55
Making audit truly educational. Postgrad Med J (1990) 3.45
Methods for comparing event rates in intervention studies when the unit of allocation is a cluster. Am J Epidemiol (1994) 3.26
Local confidential inquiry into avoidable factors in deaths from stroke and hypertensive disease. BMJ (1993) 3.25
Interpractice audit of diagnosis and management of hypertension in primary care: educational intervention and review of medical records. BMJ (1997) 3.01
Stopping treatment in patients with hypertension. BMJ (1991) 2.26
The risk of cardiovascular disease in hypertensive patients. Br J Gen Pract (1997) 2.11
Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ (1995) 2.10
Case-control study of stroke and the quality of hypertension control in north west England. BMJ (1997) 2.10
The problem of undetected and untreated hypertension in the community. Bull N Y Acad Med (1973) 2.01
The detection and management of hypertension in the elderly of Northamptonshire. J Public Health Med (1995) 1.95
Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med (1993) 1.93
Hypertension awareness, treatment and control in the community: is the 'rule of halves' still valid? J Hum Hypertens (1997) 1.76
Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort study. BMJ (1996) 1.60
Management of hypertension in twelve Oxfordshire general practices. J R Coll Gen Pract (1986) 1.43
Quality assessment of blood pressure measurements in epidemiological surveys. The impact of last digit preference and the proportions of identical duplicate measurements. WHO Monica Project [corrected]. Rev Epidemiol Sante Publique (1990) 1.19
General practitioners' knowledge of and attitudes to the management of hypertension in elderly patients. Br J Gen Pract (1994) 1.18
Blood pressure control of drug treated hypertension in 18 general practices. J Hum Hypertens (1996) 1.14
Do general practice computer systems assist in medical audit? Fam Pract (1994) 1.04
Sources of error in recording the blood pressure of patients with hypertension in general practice. Br Med J (Clin Res Ed) (1984) 1.00
Optimal blood pressure control in treated hypertensive patients. Report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation (1994) 0.96
Defining hypertension in older people from primary care case notes review. J Hum Hypertens (1997) 0.92
Observational precision in general practice data: a technique for analysis and audit. IMA J Math Appl Med Biol (1996) 0.81
Management of hypertension in the elderly: attitudes of general practitioners and hospital physicians. Br J Clin Pharmacol (1995) 0.80
Audit of diagnosis and management of hypertension in primary care. Definition of uncontrolled blood pressure used in study is unclear. BMJ (1997) 0.79
Clinical guidelines: ways ahead. J Eval Clin Pract (1998) 4.56
Data protection legislation: interpretation and barriers to research. BMJ (2000) 4.43
Life insurance and HIV antibody testing. BMJ (1992) 3.87
The Iranian health insurance system; past experiences, present challenges and future strategies. Iran J Public Health (2012) 3.28
Same information, different decisions: the influence of evidence on the management of hypertension in the elderly. Br J Gen Pract (1996) 3.15
Using clinical evidence. BMJ (2001) 2.97
Alterations in prescribing by general practitioner fundholders: an observational study. BMJ (1995) 2.96
Why do GPs not implement evidence-based guidelines? A descriptive study. Fam Pract (2001) 2.94
HIV at the hospital/general practice interface: bridging the communication divide. Int J STD AIDS (1995) 2.65
A purchaser perspective of managing new drugs: interferon beta as a case study. BMJ (1995) 2.57
The risk of cardiovascular disease in hypertensive patients. Br J Gen Pract (1997) 2.11
Involving consumers in a needs-led research programme: a pilot project. Health Expect (2001) 2.10
Which clinical studies provide the best evidence? The best RCT still trumps the best observational study. BMJ (2000) 2.06
Therapeutic conservatism. J R Coll Physicians Lond (1993) 2.02
Patient-delivered partner medication in the UK: an unlawful but popular choice. Int J STD AIDS (2007) 1.91
Pharmacoeconomics: evaluating the evaluators. Br J Clin Pharmacol (1997) 1.89
Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology (2011) 1.71
Cavernous angiomas of the tympanic membrane. Arch Otolaryngol (1972) 1.70
Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review. QJM (2003) 1.55
Lifestyle medicines. BMJ (2000) 1.50
Economic evaluation under managed competition: evidence from the U.K. Soc Sci Med (1997) 1.48
Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. Health Technol Assess (2003) 1.46
Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak? Sex Transm Infect (2007) 1.44
Imprinting of Igf2 and H19 from a 130 kb YAC transgene. Development (1997) 1.43
Clinical guidelines: development, implementation, and effectiveness. Postgrad Med J (1995) 1.43
A randomized trial of Evidence-based OutReach (EBOR): rationale and design. Control Clin Trials (1999) 1.42
Review of therapeutically equivalent alternatives to short acting beta(2) adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers. Thorax (1999) 1.42
[Genetic composition of Chilean population: the Pehuenches from Trapa-Trapa]. Rev Med Chil (1993) 1.41
The impact of health economics on healthcare delivery: the health economists' perspective. Pharmacoeconomics (2001) 1.39
Therapeutic conservatism. J R Coll Physicians Lond (1993) 1.39
Cost implications of prehospital emergency drug administration. The case of prehospital thrombolytics. Pharmacoeconomics (1996) 1.39
Health care financing in iran; is privatization a good solution? Iran J Public Health (2012) 1.38
Psychosocial implications of recurrent genital herpes simplex virus infection. Genitourin Med (1988) 1.37
Influences of practice characteristics on prescribing in fundholding and non-fundholding general practices: an observational study. BMJ (1996) 1.37
Prescribing costs in general practice fundholding. Lancet (1996) 1.27
Generic prescribing: time to regulate the market? Price rises are a blow to nascent primary care groups. BMJ (2000) 1.26
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Technol Assess (2004) 1.26
Autonomic nerve stimulation, kallikrein content anc acinar cell granules of the cat's submandibular gland. J Physiol (1975) 1.24
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Health Technol Assess (2007) 1.19
Imitation in autistic, early schizophrenic, and non-psychotic subnormal children. J Autism Child Schizophr (1973) 1.18
Coronary artery stents: a rapid systematic review and economic evaluation. Health Technol Assess (2004) 1.18
Evaluation of sperm washing as a potential method of reducing HIV transmission in HIV-discordant couples wishing to have children. AIDS (1999) 1.18
The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ (2001) 1.16
Provision of the immunoglobulin heavy chain enhancer downstream of a test gene is sufficient to confer lymphoid-specific expression in transgenic mice. Eur J Immunol (1987) 1.15
Comparison and reproducibility of transthoracic bioimpedance and dual beam Doppler ultrasound measurement of cardiac function in healthy volunteers. Br J Clin Pharmacol (1991) 1.14
Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: a study of fundholders and non-fundholders. Br J Gen Pract (1999) 1.13
Who decides when to start preventive treatment? A questionnaire survey to compare the views of different population subgroups. J Epidemiol Community Health (2003) 1.11
Addressing barriers to change: an RCT of practice-based education to improve the management of hypertension in the elderly. Br J Gen Pract (1999) 1.10
Drug-eluting stents: a systematic review and economic evaluation. Health Technol Assess (2007) 1.10
Clinical guidelines-the hidden costs. BMJ (1999) 1.09
Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population. Clin Exp Allergy (2003) 1.09
The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review. Health Technol Assess (2011) 1.08
Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses. Pharmacogenomics J (2010) 1.07
Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study. Heart (2005) 1.06
The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess (2008) 1.06
Auditory verbal hallucinations and dysfunction of the neural substrates of speech. Schizophr Res (2001) 1.05
The UK indicative prescribing scheme: background and operation. Pharmacoeconomics (1992) 1.03
Social support network characteristics and sexual risk taking among a racially/ethnically diverse sample of young, urban men who have sex with men. AIDS Behav (2013) 1.03
cDNA cloning and characterisation of novel ripening-related mRNAs with altered patterns of accumulation in the ripening inhibitor (rin) tomato ripening mutant. Plant Mol Biol (1993) 1.02
Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study. Eur J Clin Invest (1998) 1.02
Lack of an interaction between propranolol and sumatriptan. Br J Clin Pharmacol (1991) 1.02
Findings of mild traumatic brain injury in combat veterans with PTSD and a history of blast concussion. J Neuropsychiatry Clin Neurosci (1998) 1.02
Psychiatric morbidity in women attending a clinic for vulval problems--is there a higher rate in vulvodynia? Int J STD AIDS (1993) 1.01
Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection. Eur J Clin Nutr (1997) 1.01
Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. Clin Exp Allergy (2003) 1.01
Pharmacoeconomics: integrating economic evaluation into clinical trials. Br J Clin Pharmacol (1997) 0.99
Olfactory neuroblastoma. Management and prognosis. Arch Otolaryngol (1975) 0.98
Human antibody production in transgenic mice: expression from 100 kb of the human IgH locus. Eur J Immunol (1991) 0.96
Sialotonin: vasopressor substance in saliva and submandibular gland of the cat. J Physiol (1976) 0.95
FHSA medical advisers: friends or foes? BMJ (1992) 0.94
Supply and regulation of medicines. BMJ (2005) 0.94
The management of Pneumocystis carinii pneumonia. Br J Clin Pharmacol (1999) 0.93
Medication errors in primary care in Riyadh City, Saudi Arabia. East Mediterr Health J (2011) 0.93
Prognosis in autism: a follow-up study. J Autism Child Schizophr (1973) 0.92
The psychological consequences in patient undergoing a POCKit HSV-2 test. Int J STD AIDS (2000) 0.92
A double-blind randomised placebo-controlled trial of topical intranasal corticosteroids in 4- to 11-year-old children with persistent bilateral otitis media with effusion in primary care. Health Technol Assess (2009) 0.92
Medicines regulation and health technology assessment. Clin Pharmacol Ther (2010) 0.92
Risk sharing and payment by results. Clin Pharmacol Ther (2008) 0.92
A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience. Int J STD AIDS (2012) 0.92
HSV-2 specific serology should not be offered routinely to antenatal patients. Rev Med Virol (2000) 0.91
Differentiation of the myocardial rudiment of mouse embryos: an ultrastructural study including freeze-fracture replication. J Anat (1986) 0.91
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation. Health Technol Assess (2009) 0.91
Centralized obesity and cardiovascular disease risk in Mexican Americans. Am J Epidemiol (1987) 0.91
Tandemly repeated transgenes of the human minisatellite MS32 (D1S8), with novel mouse gamma satellite integration. Nucleic Acids Res (1994) 0.90
Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma. Thorax (2003) 0.89
Communication with general practitioners by hospital-based HIV units. Int J STD AIDS (1995) 0.89
Parental practices and innate activity in normal, autistic, and brain-damaged infants. J Autism Child Schizophr (1972) 0.89
GP facilitators and HIV infection. GPs should be involved early. BMJ (1994) 0.89
Performance indicators for primary care groups. Performance of these indicators is critical. BMJ (1999) 0.88
Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes. Cochrane Database Syst Rev (2005) 0.88
Accounting for noncompliance in pharmacoeconomic evaluations. Pharmacoeconomics (2001) 0.88
Integrating clinical pharmacology in a new problem based medical undergraduate curriculum. Br J Clin Pharmacol (1997) 0.88
Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies. Health Technol Assess (2006) 0.88
Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels. Diabetologia (2006) 0.88